Combined inhibitors of angiogenesis and histone deacetylase: Efficacy in rat hepatoma

doi:10.3748/wjg.v17.i31.3623

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 17, Issue 31

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (3099)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-3) series, Tables (1-2) series.

Item

Count

PDF

323

HTML

2338

Figures (1-3)

214

Tables (1-2)

224

Sum=3099

Aug 21, 2011 (publication date) through Jan 24, 2025

Times Cited of This Article

Times Cited (2)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastroenterol. Aug 21, 2011; 17(31): 3623-3629
Published online Aug 21, 2011. doi: 10.3748/wjg.v17.i31.3623

Full Size Figure Download Figure

Figure 3 Hematoxylin-eosin and proliferating cell nuclear antigen staining. A: Control 1, hematoxylin-eosin staining. B: Quadruple therapy, disintegrating cells, necrosis. C: Control 1, proliferating cell nuclear antigen (PCNA) staining for proliferating cells. D: Quadruple therapy, PCNA staining, reduced number of cells, and large necrotic area.

Citation: Ganslmayer M, Zimmermann A, Zopf S, Herold C. Combined inhibitors of angiogenesis and histone deacetylase: Efficacy in rat hepatoma. World J Gastroenterol 2011; 17(31): 3623-3629
URL: https://www.wjgnet.com/1007-9327/full/v17/i31/3623.htm
DOI: https://dx.doi.org/10.3748/wjg.v17.i31.3623